{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:47:33Z","timestamp":1759333653273,"version":"3.40.5"},"reference-count":28,"publisher":"FapUNIFESP (SciELO)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["An. Bras. Dermatol."],"published-print":{"date-parts":[[2013,8]]},"abstract":"<jats:p>BACKGROUND: HIV\/AIDS-Associated Lipodystrophy Syndrome includes changes in body fat distribution, with or without metabolic changes. The loss of fat from the face, called facial lipoatrophy, is one of the most stigmatizing signs of the syndrome.OBJECTIVES:To evaluate the effect of FL treatment using polymethylmethacrylate (PMMA) implants on disease progression, assessed by viral load and CD4 cell count.METHODS: This was a prospective study of 44 patients treated from July 2009 to December 2010. Male and female patients, aged over 18 years, with clinically detectable FL and who had never been treated were included in the study. PMMA implantation was done to fill atrophic areas. Laboratory tests were conducted to measure viral load and CD4 count before and after treatment.RESULTS: Of the 44 patients, 72.72% were male and 27.27% female, mean age of 44.38 years. Before treatment, 82% of patients had undetectable viral load, which increased to 88.6% after treatment, but without statistical significance (p = 0.67). CD4 count before treatment ranged from 209 to 1293, averaging 493.97. After treatment, the average increased to 548.61. The increase in CD4 count after treatment was statistically significant with p = 0.02.CONCLUSION: The treatment of FL with PMMA implants showed a statistically significant increase in CD4 count after treatment, revealing the impact of FL treatment on disease progression. Viral load before and after treatment did not vary significantly.<\/jats:p>","DOI":"10.1590\/abd1806-4841.2013895","type":"journal-article","created":{"date-parts":[[2013,10,2]],"date-time":"2013-10-02T22:00:03Z","timestamp":1380751203000},"page":"570-577","source":"Crossref","is-referenced-by-count":6,"title":["Treatment of HIV-associated facial lipoatrophy: impact on infection progression assessed by viral load and CD4 count"],"prefix":"10.1590","volume":"88","author":[{"given":"Fl\u00e1via Machado Gon\u00e7alves","family":"Soares","sequence":"first","affiliation":[{"name":"University of Brasilia, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izelda Maria Carvalho","family":"Costa","sequence":"additional","affiliation":[{"name":"Federal University of S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulinresistance in patients receiving HIV protease inhibitors","volume":"12","author":"Carr A","year":"1998","journal-title":"AIDS"},{"key":"ref2","first-page":"546","article-title":"Psychosocial impact of the lipodystrophy syndrome in HIV infection","volume":"10","author":"Collins E","year":"2000","journal-title":"AIDS Read"},{"year":"2009","series-title":"Manual de tratamento da lipoatrofia facial: recomenda\u00e7\u00f5es para o preenchimento facial com polimetilmetacrilato em portadores de HIV\/AIDS","key":"ref3"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2165\/00002018-200023010-00004","article-title":"Lipodystrophy syndrome in HIV infection: what is it, what causes it and how can it be managed?","volume":"23","author":"Behrens GMN","year":"2000","journal-title":"Drug Saf"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1089\/apc.2009.0191","article-title":"Prevalence and impact of body physical changes in HIV patients treated with highly active antiretroviral therapy: results from a study on patient and physician perceptions","volume":"24","author":"Cabrero E","year":"2010","journal-title":"AIDS Patient Care STDS"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1210\/jc.2002-020794","article-title":"Clinical review 153: Lipodystrophy in human immunodeficiency virus-infected patients","volume":"87","author":"Chen D","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1155\/2005\/303141","article-title":"HIV-associated lipodystrophy syndrome: A review of clinical aspects","volume":"16","author":"Baril JG","year":"2005","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"ref8","first-page":"23","article-title":"S\u00edndrome Lipodistr\u00f3fica e HIV\/AIDS","volume":"3","author":"Li HY","year":"2002","journal-title":"J Bras Aids"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/09540120701868345","article-title":"The face of HIV and AIDS: can we erase the stigma?","volume":"20","author":"Kavouni A","year":"2008","journal-title":"AIDS Care"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/jac\/dki165","article-title":"Current perspectives on HIV-associated lipodystrophy syndrome","volume":"56","author":"Milinkovic A","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0190-9622(00)90125-7","article-title":"HIV-1 protease inhibitor-associated partial lipodystrophy: clinicopathologic review of 14 cases","volume":"42","author":"Pujol RM","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1155\/2005\/303141","article-title":"HIV-associated lipodystrophy syndrome: A review of clinical aspects","volume":"16","author":"Baril JG","year":"2005","journal-title":"Infect Dis Med Microbiol"},{"key":"ref13","first-page":"S100","article-title":"Minimizing Adverse Events Associated with Poly-L-latic Acid Injection","volume":"34","author":"Narins RS","year":"2008","journal-title":"Dermatol Surg"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1089\/apc.2008.0230","article-title":"A systematic review of permanent and semipermanent dermal fillers for HIV-associated facial lipoatrophy","volume":"23","author":"Sturm LP","year":"2009","journal-title":"AIDS Patient Care STDS"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1468-1293.2009.00761.x","article-title":"Large particle hyaluronic acid for the treatment of facial lipoatrophy in HIV-positive patients: 3-year follow-up study","volume":"11","author":"Skeie L","year":"2010","journal-title":"HIV Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1468-1293.2006.00342.x","article-title":"Long-term safety and efficacy of poly-Llactic acid in the treatment of HIV-related facial lipoatrophy","volume":"7","author":"Moyle GJ","year":"2006","journal-title":"HIV Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1007\/s11136-006-9001-7","article-title":"Quality of life in HIV subtype C infection among asymptomatic subjects and its association with CD4 counts and viral loads--a study from South India","volume":"15","author":"Chandra PS","year":"2006","journal-title":"Qual Life Res"},{"key":"ref18","first-page":"235","article-title":"Terapia Anti-retroviral","author":"Lomar AV","year":"2005","journal-title":"Tratado de infectologia"},{"key":"ref19","series-title":"Tratado de infectologia","first-page":"138","volume-title":"Imunopatog\u00eanese","author":"Rizzo LV","year":"2005"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/01.psy.0000188569.58998.c8","article-title":"Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment","volume":"67","author":"Ironson G","year":"2005","journal-title":"Psychosom Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1037\/0022-006X.70.3.537","article-title":"Psychoneuroimmunology: psychological influences on immune function and health","volume":"70","author":"Kiecolt-Glaser J","year":"2002","journal-title":"J Consult Clin Psychol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1176\/appi.ajp.159.1.143","article-title":"Stress Management andImmune System Reconstitution in Symptomatic HIV-Infected Gay Men Over Time: EffectsonTransitionalNa\u00efve T Cells (CD4+CD45RA+CD29+)","volume":"159","author":"Antoni MH","year":"2002","journal-title":"Am J Psychiatry"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/01.psy.0000116782.49850.d3","article-title":"Effect of written emotional expression on immune function in patients with human immunodeficiency virus infection: a randomized trial","volume":"66","author":"Petrie KJ","year":"2004","journal-title":"Psychosom Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/08964280009595761","article-title":"Psychological stress may induce increased humoral and decreased cellular immunity","volume":"26","author":"Paik IH","year":"2000","journal-title":"Behav Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1590\/S1516-44462006005000052","article-title":"Neuroimunomodula\u00e7\u00e3o: sobre o di\u00e1logo entre os sistemas nervoso e imune","volume":"29","author":"Alves GJ","year":"2007","journal-title":"Rev Bras Psquiatr"},{"key":"ref26","first-page":"18","article-title":"Mind, immunity and health - the science and clinical application of psychoneuroimmunology","volume":"26","author":"Kooker M","year":"2008","journal-title":"CME"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s10880-008-9133-8","article-title":"CD4 count and physical symptoms among urban African American mothers with HIV: an examination of the role of optimism and depressive symptoms","volume":"15","author":"O'Connell-Edwards C","year":"2008","journal-title":"J Clin Psychol Med Settings"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1590\/S0102-79722002000100013","article-title":"Psiconeuroimunologia e infec\u00e7\u00e3o por HIV: realidade ou fic\u00e7\u00e3o?","volume":"15","author":"Ulla S","year":"2002","journal-title":"Psicol Reflex Crit"}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/abd\/v88n4\/0365-0596-abd-88-4-0570.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T15:00:42Z","timestamp":1747666842000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0365-05962013000400570&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0365-05962013000400570"],"URL":"https:\/\/doi.org\/10.1590\/abd1806-4841.2013895","relation":{},"ISSN":["0365-0596"],"issn-type":[{"type":"electronic","value":"0365-0596"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}